Previous Exposure to HCV Among Persons Born During 1945―1965: Prevalence and Predictors, United States, 1999―2008

We examined HCV exposure prevalence and predictors among persons in the United States born during 1945-1965. With data from the 1999-2008 National Health and Nutrition Examination Survey, we calculated the proportion of persons born during 1945-1965 who tested positive for HCV antibody (anti-HCV) an...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of public health (1971) Vol. 104; no. 3; pp. 474 - 481
Main Authors SMITH, Bryce D, BECKETT, Geoff A, YARTEL, Anthony, HOLTZMAN, Deborah, PATEL, Nita, WARD, John W
Format Journal Article
LanguageEnglish
Published Washington, DC American Public Health Association 01.03.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We examined HCV exposure prevalence and predictors among persons in the United States born during 1945-1965. With data from the 1999-2008 National Health and Nutrition Examination Survey, we calculated the proportion of persons born during 1945-1965 who tested positive for HCV antibody (anti-HCV) and analyzed the prevalence by sociodemographic and behavioral risk factors. Anti-HCV prevalence in the 1945-1965 birth cohort was 3.2% (95% confidence interval [CI] = 2.8%, 3.8%), substantially higher than among other adults (0.9%). Within the cohort, anti-HCV prevalence was higher among non-Hispanic Blacks (6.4%; 95% CI = 5.3%, 7.7%), persons with injection drug use histories (56.8%; 95% CI = 48.4%, 64.8%), and persons with elevated alanine aminotransferase levels (12.7%; 95% CI = 10.7%, 15.1%). Injection drug use (adjusted odds ratio = 98.4; 95% CI = 58.8, 164.5) was the strongest anti-HCV prevalence predictor. Among anti-HCV-positive persons, 57.8% reported having 2 or more alcoholic drinks daily. With the high prevalence of HCV among persons born during 1945-1965, the increasing morbidity and mortality associated with HCV, and reductions in liver cancer and HCV-related mortality when HCV is eradicated, it is critically important to identify persons with HCV and link them to appropriate care.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Peer Reviewed
B. D. Smith contributed to the original conceptualization, study design, first draft of article, data analysis direction and interpretation, and critical article revisions. G. A. Beckett contributed to the study design, data interpretation, and critical article revisions. A. Yartel contributed to the study design; data management, analysis, and interpretation; first draft of article; and critical article revisions. D. Holtzman contributed to data analysis, data interpretation, and critical article revisions. N. Patel contributed to data analysis and interpretation. J. W. Ward contributed to critical article revisions and data interpretation.
Contributors
ISSN:0090-0036
1541-0048
DOI:10.2105/AJPH.2013.301549